Amedisys Inc
NASDAQ:AMED
Amedisys Inc
NASDAQ:AMED
Price:
94.95 USD
-0.57%
Market Closed
Updated:
May 17, 2024
Amedisys Inc
Operating Expenses
|
Amedisys Inc
Operating Expenses Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Operating Expenses
-$816.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-5%
|
|
|
DaVita Inc
NYSE:DVA
|
Operating Expenses
-$2.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Operating Expenses
-$1.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
|
CVS Health Corp
NYSE:CVS
|
Operating Expenses
-$40.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-10%
|
|
|
Cigna Corp
NYSE:CI
|
Operating Expenses
-$16.2B
|
CAGR 3-Years
53%
|
CAGR 5-Years
25%
|
CAGR 10-Years
6%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Operating Expenses
-$2.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-7%
|
See Also
What is Amedisys Inc's Operating Expenses?
Operating Expenses
-816.5m
USD
-816.5m
USD
Based on the financial report for Mar 31, 2024, Amedisys Inc's Operating Expenses amounts to -816.5m USD.
What is Amedisys Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-5%
-5%
Over the last year, the Operating Expenses growth was -3%. The average annual Operating Expenses growth rates for Amedisys Inc have been -5% over the past three years , -9% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
